Navigation Links
Radiofrequency Ablation Devices Market is Expected to Reach USD 1.0 Billion Globally in 2018: Transparency Market Research
Date:7/22/2013

Albany, NY (PRWEB) July 22, 2013

According to a new market report published by Transparency Market Research, "Radiofrequency Ablation Devices Market for Pain Management- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the global radiofrequency ablation devices market for pain management was valued at USD 296.6 million in 2011, and is expected to grow at a CAGR of 19.4% from 2012 to 2018, and to reach an estimated value of USD 1,027.6 million in 2018.

Related Report : Biosensors Market
http://www.transparencymarketresearch.com/biosensors-market.html

Radiofrequency ablation is a minimally invasive surgical procedure involving temperature controlled destruction of dysfunctional or cancerous tissues. Use of this technology for pain management refers to heat destruction of nerves conducting pain impulses, to relieve the patient of chronic pain. The market for RF ablation devices for pain management application is expected to record a high growth rate during the forecast period, owing to the rising demand of minimally invasive surgeries, high efficacy and short duration of the procedure.

The disposables segment accounted for the largest share of the market in 2011 and is expected to be the fastest growing segment during the forecast period. This was followed by the capital equipment segment and the reusables segment in 2011. Geographically, North America accounted for the largest share in 2011, while Asia-Pacific is expected to be the fastest growing region from 2012 to 2018 at a CAGR of 20.6%.

Browse the full report with TOC at http://www.transparencymarketresearch.com/radiofrequency-ablation-devices.html

This market is dominated by a few major players, namely, Cosman Medical, Integra-Radionics, Kimberly Clark-Baylis, NeuroTherm and Stryker Corporation. Of these, Kimberly-Clark accounted for the largest market share in 2011, followed by NueroTherm.

Radiofrequency ablation is a medical procedure involving use of high frequency electromagnetic waves to generate heat which is used to treat a medical condition. This technology finds application in various fields of medicine like tumor ablation in oncology, cardiac rhythm management, endometrial ablation in gynecology, renal denervation for hypertension, cosmetology and pain management. This report focuses on the RF ablation devices market for the pain management application area. The basic principle underlying pain management using RF ablation is heating up the nerves that send pain signals to the affected area so that their impulse transfer activity is hampered.

Browse All Market Research Reports: http://www.transparencymarketresearch.com/

Read the full story at http://www.prweb.com/releases/2013/7/prweb10950371.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. GAP-AF study helps to define optimal approach to ablation
2. New ablation technique holds promise for liver cancer patients
3. INTIO Introduces Intra-Procedural SyncVIEW™ for Real-time Confirmation of the Ablation Zone
4. Gold standards of success defined for AF ablation
5. Fine tuning cardiac ablation could lead to quicker results for patients with arrhythmias
6. Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent)
7. Endoscopy Devices Market Worth $9.7 Billion by 2016 - New Report by MarketsandMarkets
8. Mesh Lawsuits Involving C.R. Bard, Ethicon Transvaginal Mesh Devices Continue to Mount in New Jersey State Litigation, Bernstein Liebhard LLP Reports
9. Manufacturers Failed to Warn About Defective Transvaginal Mesh Devices, Parker Waichman LLP Alleges in Lawsuit
10. Spinal Surgery and Implants Devices Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research
11. Rijuven Debuts CardioSleeve, an FDA Cleared Stethoscope Attachment with 3-Lead ECG and Digital Auscultation that Wirelessly Connects to Mobile Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... On Dec. ... the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who have ... (MPNs) by going above and beyond the standard of care, demonstrating leadership within the ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... the launch of its 60-day free trial program for all of the company’s ... the offer a truly hassle free experience. , FlexiSpot’s unique desktop risers use ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of ... of an injury, patients must find the one that works for them. When an ... created a machine that worked and decided to share it with others. , He ...
(Date:12/2/2016)... ... 02, 2016 , ... Mediaplanet is proud to announce the ... the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and ... 6 years in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned ...
(Date:12/2/2016)... ... December 02, 2016 , ... Sourced from the Isbre Springs beneath the ... its unmatched natural purity of just 6 ppm TDS (Total Dissolved Solids) in addition ... has been available in several ShopRite and FoodTown stores in NJ and received rave ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 2, 2016  The Addiction Treatment ... Academy of Managed Care Pharmacy (AMCP), has released ... better address the opioid addiction crisis, including through ... (MAT). ATAG,s newly released paper, "The ... to Naloxone," addresses many issues around gaps and ...
(Date:12/2/2016)... R.I. , Dec. 2, 2016 CVS ... its annual Analyst Day in New York City on Thursday, December 15, ... CVS Health leadership team will provide an in-depth review ... enhance shareholder value. The company will also discuss 2017 ... and video webcast of the event will be broadcast ...
(Date:12/2/2016)... Dec. 2, 2016   CytoSorbents Corporation (NASDAQ: ... its European Union approved CytoSorb ® cytokine adsorber ... patients worldwide, announced that Dr. Phillip Chan , ... Annual LD Micro Main Event investor conference held ... the Luxe Sunset Boulevard Hotel in Los ...
Breaking Medicine Technology: